Hungary vs Russian Federation: Hepatitis B surface antigen (HBsAg) prevalence
Hungary
0.1%
in 2024
Russian Federation
0.1%
in 2024
Hungary rank
101st
Russian Federation rank
101st
Hepatitis B surface antigen (HBsAg) prevalence over time
- Hungary
- Russian Federation
How they compare
Hungary currently reports 0.1% against 0.1% in Russian Federation, a difference of 0.0%.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Hungary ahead.
Hungary ranks 101st and Russian Federation ranks 101st of 194 countries.
Hungary has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Hungary | Russian Federation | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.1% | 0.0% | Hungary |
| 2020s | 0.1% | 0.1% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Hungary or Russian Federation?
- Hungary, at 0.1% against 0.1% in Russian Federation as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Hungary and Russian Federation?
- 0.0%, with Hungary ahead.
- How many years of comparable data are there for Hungary and Russian Federation?
- 10 years are reported by both, from 2015 to 2024.
- How do Hungary and Russian Federation rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Hungary ranks 101st and Russian Federation ranks 101st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.